These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11852962)

  • 1. Monitoring drug therapy in the intensive care unit.
    Cuddy PG
    Crit Care Nurs Q; 2000 Feb; 22(4):14-22. PubMed ID: 11852962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug use and nephrotoxicity in the intensive care unit.
    Perazella MA
    Kidney Int; 2012 Jun; 81(12):1172-8. PubMed ID: 21124300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A focus on medication safety in the intensive care unit.
    Patel G
    Curr Drug Saf; 2010 Jan; 5(1):1. PubMed ID: 20218962
    [No Abstract]   [Full Text] [Related]  

  • 4. Interventions of a clinical pharmacist in a medical intensive care unit - A retrospective analysis.
    Cvikl M; Sinkovič A
    Bosn J Basic Med Sci; 2020 Feb; 20(4):495-501. PubMed ID: 32070269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the TIM program (Transfer ICU Medication reconciliation) on medication transfer errors in two Dutch intensive care units: design of a prospective 8-month observational study with a before and after period.
    Bosma BE; Meuwese E; Tan SS; van Bommel J; Melief PH; Hunfeld NG; van den Bemt PM
    BMC Health Serv Res; 2017 Feb; 17(1):124. PubMed ID: 28183302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication errors and adverse drug events in an intensive care unit: direct observation approach for detection.
    Kopp BJ; Erstad BL; Allen ME; Theodorou AA; Priestley G
    Crit Care Med; 2006 Feb; 34(2):415-25. PubMed ID: 16424723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of a daily "medication time out" in the Intensive Care Unit.
    Tainter CR; Nguyen AP; Pollock KA; O'Brien EO; Lee J; Schmidt U; Jahanasouz F; Owens RL; Meier A
    J Crit Care; 2018 Feb; 43():366-369. PubMed ID: 28939276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of potential drug-drug interactions in medical intensive care unit patients.
    Uijtendaal EV; van Harssel LL; Hugenholtz GW; Kuck EM; Zwart-van Rijkom JE; Cremer OL; Egberts TC
    Pharmacotherapy; 2014 Mar; 34(3):213-9. PubMed ID: 24390929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units.
    Cullen DJ; Sweitzer BJ; Bates DW; Burdick E; Edmondson A; Leape LL
    Crit Care Med; 1997 Aug; 25(8):1289-97. PubMed ID: 9267940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring in the neurocritical care unit.
    Loh GW; Mabasa VH; Ensom MH
    Curr Opin Crit Care; 2010 Apr; 16(2):128-35. PubMed ID: 20168225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical review: medication errors in critical care.
    Moyen E; Camiré E; Stelfox HT
    Crit Care; 2008; 12(2):208. PubMed ID: 18373883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of medication therapy management on pharmacotherapy safety in an intensive care unit.
    Martins RR; Silva LT; Lopes FM
    Int J Clin Pharm; 2019 Feb; 41(1):179-188. PubMed ID: 30552623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Drug Interaction Stewardship" (DIS) and Therapeutic Drug Monitoring for Anti-infective Treatment in Intensive Care, a Single Centre Observational Study].
    Lodes U; Troeger U; Neuling F; Jacob D; Meyer F
    Zentralbl Chir; 2020 Apr; 145(2):176-187. PubMed ID: 31711246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic predisposition to adverse drug reactions in the intensive care unit.
    Empey PE
    Crit Care Med; 2010 Jun; 38(6 Suppl):S106-16. PubMed ID: 20502164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of voluntarily reported medication errors in intensive care and general care units.
    Kane-Gill SL; Kowiatek JG; Weber RJ
    Qual Saf Health Care; 2010 Feb; 19(1):55-9. PubMed ID: 20172884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug-drug interactions in medical intensive care patients.
    Rivkin A; Yin H
    J Crit Care; 2011 Feb; 26(1):104.e1-6. PubMed ID: 20646898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Patient Safety Threats in a Post-Intensive Care Clinic.
    Karlic KJ; Valley TS; Cagino LM; Prescott HC; Iwashyna TJ; Mohammad RA; Pitcher M; Haezebrouck E; McSparron JI
    Am J Med Qual; 2023 May-Jun 01; 38(3):117-121. PubMed ID: 36951467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.
    Wong G; Brinkman A; Benefield RJ; Carlier M; De Waele JJ; El Helali N; Frey O; Harbarth S; Huttner A; McWhinney B; Misset B; Pea F; Preisenberger J; Roberts MS; Robertson TA; Roehr A; Sime FB; Taccone FS; Ungerer JP; Lipman J; Roberts JA
    J Antimicrob Chemother; 2014 May; 69(5):1416-23. PubMed ID: 24443514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.